Welcome8:00 AM to 8:05 AM  | Speaker: Elizabeth A. Farrington, Pharm.D., B.S.Pharm, FCCP, FCCM, FPPA, BCNSP, BCPPS, BCPS
Title: Welcome
Institution: New Hanover Regional Medical Center
City/State: Wilmington, NC
View Biography |
|
New Educator Award8:00 AM to 8:15 AM  | Award Winner: Paul M. Boylan, Pharm.D., BCPS
Title: New Educator Award
Institution: The University of Oklahoma College of Pharmacy
City/State: Oklahoma City, OK
View Biography |
|
New Clinical Practitioner Award8:15 AM to 8:25 AM  | Award Winner: Wesley D. Kufel, Pharm.D., BCIDP, BCPS, AAHIVP
Title: New Clinical Practitioner Award
Institution: Binghamton University School of Pharmacy and Pharmaceutical Sciences
City/State: Camillus, NY
View Biography |
|
New Investigator Award/Lecture — Rationally Optimized Antibiotic Combinations for Carbapenem-Resistant Klebsiella pneumoniae8:25 AM to 8:45 AM
Available for 0.25 hours of CPE credit
Activity Number: 0217-0000-23-190-L01-P
Activity Type: A Knowledge-Based Activity
Infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp) are an urgent public health threat since they are associated with mortality rates of up to 34% and treatment options are very limited. Antibiotic combinations are frequently employed to treat CR-Kp. However, the approach for choosing antibiotics and dosing regimens to use in combinations to treat infections caused by CR-Kp have not been rationally optimized. This lecture will discuss new approaches to selecting antibiotics for combination therapy treatment of CR-Kp infections.  | Award Winner: Zackery P. Bulman, Pharm.D.
Title: New Investigator Award/Lecture — Rationally Optimized Antibiotic Combinations for Carbapenem-Resistant Klebsiella pneumoniae
Institution: University of Illinois at Chicago
City/State: Chicago, IL
View Biography |
Learning Objectives 1. Describe the limitations of current treatment options for serious infections caused by carbapenem-resistant Klebsiella pneumonia. 2. Discuss the benefits of identifying bacterial resistance genes to provide patient-specific therapy through molecular rapid diagnostics. 3. Identify alternative combination treatment strategies for carbapenem-resistant Klebsiella pneumoniae. |
Education Award8:45 AM to 8:55 AM  | Award Winner: Angela Shogbon Nwaesei, Pharm.D., BCPS
Title: Education Award
Institution: Mercer University College of Pharmacy
City/State: Lilburn, GA
View Biography |
|
Clinical Practice Award8:55 AM to 9:05 AM  | Award Winner: Sonak Pastakia, Pharm.D., Ph.D., MPH, FCCP
Title: Clinical Practice Award
Institution: Purdue University
City/State: Indianapolis, IN
View Biography |
|
Russell R. Miller Award9:05 AM to 9:15 AM  | Award Winner: Manjunath P. Pai, Pharm.D.
Title: Russell R. Miller Award
Institution: University of Michigan, College of Pharmacy
City/State: Ypsilanti, MI
View Biography |
|
Robert M. Elenbaas Service Award9:15 AM to 9:25 AM  | Award Winner: J. Herbert Patterson, Pharm.D., FCCP
Title: Robert M. Elenbaas Service Award
Institution: University of North Carolina
City/State: Chapel Hill, NC
View Biography |
|
Warren E. Weaver/Richard P. Penna Award9:25 AM to 9:35 AM | Award Winner: Elizabeth A. Farrington, Pharm.D., B.S.Pharm, FCCP, FCCM, FPPA, BCNSP, BCPPS, BCPS
Title: Warren E. Weaver/Richard P. Penna Award
Institution: New Hanover Regional Medical Center
City/State: Wilmington, NC
View Biography |
|
Paul F. Parker Medal Award9:35 AM to 9:45 AM  | Award Winner: Bradley A. Boucher, Pharm.D., FCCP, FNAP, MCCM
Title: Paul F. Parker Medal Award
Institution: College of Pharmacy, University of Tennessee Health Science Center
City/State: Collierville, TN
View Biography |
|
Break9:45 AM to 9:55 AM |
Outgoing President's Address9:55 AM to 10:15 AM | Speaker: Elizabeth A. Farrington, Pharm.D., B.S.Pharm, FCCP, FCCM, FPPA, BCNSP, BCPPS, BCPS
Title: Outgoing President's Address
Institution: New Hanover Regional Medical Center
City/State: Wilmington, NC
View Biography |
|
Incoming President’s Address10:15 AM to 10:35 AM  | Speaker: Brian A. Hemstreet, Pharm.D., FCCP, BCPS
Title: Incoming President’s Address
Institution: University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
City/State: Aurora, CO
View Biography |
|
Therapeutic Frontiers Lecture — Expanding our Understanding and Stewardship of Drug Related Kidney Diseases10:35 AM to 11:10 AM
Available for 0.50 hours of CPE credit
Activity Number: 0217-0000-23-195-L05-P
Activity Type: A Knowledge-Based Activity
Acute kidney injury (AKI) occurs in up to 22% of hospitalized patients and 65% of critically ill patients. Drugs contribute to approximately 30% of AKI cases in hospitalized patient. The incidence and patient outcomes associated with drug-associated AKI (D-AKI) is concerning and diligent surveillance is needed. Understanding D-AKI begins with standardized definitions and classification framework ensure consistency. Developing a comprehensive nephrotoxin stewardship program will provide structured prevention and management strategies. This presentation emphasizes a fundamental understanding of what D-AKI is and approaches for stewardship.  | Award Winner: Sandra L. Kane-Gill, Pharm.D., FCCP
Title: Therapeutic Frontiers Lecture — Expanding our Understanding and Stewardship of Drug Related Kidney Diseases
Institution: University of Pittsburgh
City/State: Pittsburgh, PA
View Biography |
Learning Objectives 1. Review the contemporary definitions and classification framework for drug related kidney diseases. 2. Summarize the goals of nephrotoxin stewardship. 3. Explain hypervigilance and early detection of drug related kidney diseases as an approach to nephrotoxin stewardship. |
ACCP Foundation11:10 AM to 11:25 AM  | Speaker: Jeffrey R. Bishop, Pharm.D., MS, FCCP, BCPP
Title: ACCP Foundation
Institution: University of Minnesota
City/State: Minneapolis, MN
View Biography |
|
Pharmacotherapy Publications, Inc: Pharmacotherapy and JACCP11:25 AM to 11:30 AM  | Speaker: James E. Tisdale, Pharm.D., FCCP, BCPS
Title: Pharmacotherapy Publications, Inc: Pharmacotherapy and JACCP
Institution: Purdue University
City/State: Indianapolis, IN
View Biography |
|
Recognition of New Fellows11:30 AM to 11:45 AM | Speaker: Elizabeth A. Farrington, Pharm.D., B.S.Pharm, FCCP, FCCM, FPPA, BCNSP, BCPPS, BCPS
Title: Recognition of New Fellows
Institution: New Hanover Regional Medical Center
City/State: Wilmington, NC
View Biography |
|